EasySep™小鼠TIL（CD45）正选试剂盒
搜索结果: 'methocult media formulations for mouse hematopoietic cells serum containing'
-
STEMCELL Technologies Launches Innovative Products to Support CAR T Cell Research STEMCELL Technologies Inc. announces the launch of ImmunoCult™ Human T Cell Activator reagents and ImmunoCult™-XF T Cell Expansion Medium to support T cell researchers in their goal to develop CAR T cell immunotherapeutics -
STEMCELL Technologies Signs Exclusive License Agreement with Cincinnati Children’s for Stem Cell-Derived Organoid Technology This agreement grants STEMCELL a license to novel methods for generating organoid models and to develop cell culture media and tools that would enable scientists to create organoids from PSCs in their own laboratories -
Intestinal Organoid In-Person Training Course This two-day, in-person course covers more advanced procedures within the mouse intestinal organoid workflow. This includes how to efficiently isolate intestinal crypts from mouse small intestine, the culture of organoids using a defined serum-free medium, as well as common downstream applications. -
Human Pluripotent Stem Cell and Organoid Workshop A comprehensive 3 day workshop on methods to maintain human stem cells in culture, and the directed differentiation of these cells to either definitive endoderm or neuronal progenitor cells. We will also cover generation and support of mouse organoid cultures from intestinal crypts.
-
New Video: Untouched cells in one step with RosetteSep™ STEMCELL Technologies is proud to present an exciting new video showcasing RosetteSep™, a one-step cell separation procedure by negative selection -
ENKAM Pharmaceuticals A/S Commercial Partnership with STEMCELL Technologies Inc ENKAM Pharmaceuticals A/S (ENKAM), a privately held Danish biopharmaceutical development company focused on cancer and central nervous system disorders, is pleased to announce that it has signed a licensing and development agreement with STEMCELL Technologies Inc. -
STEMCELL Technologies Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies STEMCELL Technologies has signed a patent license agreement with iPS Academia Japan, Inc. to license and commercialize iPS Academia Japan, Inc.'s patented technologies for induced pluripotent stem cell (iPS cell) research -
STEMCELL Technologies Receives ISO 13845:2003 Certification STEMCELL Technologies Inc (STEMCELL), a leader in specialty cell culture media, cell separation products and ancillary reagents for life science research, is pleased to announce that it has successfully achieved ISO 13485:2003 certification for its research, manufacturing and shipping facilities in Vancouver, BC, Canada and Tukwila, WA, USA -
STEMCELL Technologies Launches mTeSR™ Plus, a Next-Generation Culture System for Human ES and iPS Cell Maintenance The new medium has undergone successful beta testing with several members of the Stem Cell COREdinates group and has completed rigorous in-house validation testing
